Literature DB >> 17345022

[Extraordinary manifestation of a gastric carcinoma by leptomeningeal carcinomatosis and spinal metastasis].

Nicola Cresto1, Alain Barth, Marlene Arnold, Rosemarie Weimann, Jürgen Gschossmann, Adrian F Ochsenbein, Christos Kolotas, Hans-Jakob Peter, Uwe Schiemann.   

Abstract

BACKGROUND: Leptomeningeal carcinomatosis is a rare complication of solid tumors, e. g., breast, lung and gastrointestinal carcinomas. Clinical manifestations are variable with radicular pains with or without neurologic deficiencies as well as headache and hallucinations. CASE REPORT: The rare case of a 57-year-old patient with neurologic symptoms caused by a leptomeningeal carcinomatosis and a spinal metastasis of an asymptomatic signet-ring cell gastric carcinoma is reported. In spite of combined radiochemotherapy the patient died already 4 weeks after discharge from hospital due to an intracerebral hemorrhage.
CONCLUSION: Until today, prognosis of leptomeningeal carcinomatosis is poor with a median survival between 3-4 months independently of the primary tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17345022     DOI: 10.1007/s00063-007-1030-7

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

1.  Intracranial hypertension as the presenting symptom of duodenal cancer.

Authors:  Çağdaş Erdoğan; Eylem Değirmenci; Nedim Ongun; Levent Sinan Bir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

Review 2.  Modern management of rare brain metastases in adults.

Authors:  Matthias J Krammer; Andre Tomasino; David B Schul; Sabrina T Astner; Michael P Meier; Christianto B Lumenta
Journal:  J Neurooncol       Date:  2011-06-21       Impact factor: 4.130

Review 3.  Intracranial hypertension as the primary symptom of gastric signet-ring cell carcinoma: A case report and literature review.

Authors:  Jiali Pu; Lingjia Xu; Xinzhen Yin; Baorong Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.